The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
about
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyCombination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaBHistone deacetylase inhibitors for purging HIV-1 from the latent reservoir.Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.Targeting HIV latency: pharmacologic strategies toward eradication.Altering cell death pathways as an approach to cure HIV infection.Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells.Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors.Early events of HIV-1 infection: can signaling be the next therapeutic target?HDAC inhibitors in HIV.HIV reservoirs and strategies for eradication.HIV-1 latency in monocytes/macrophagesHistonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitorsRelationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.Modeling the timing of antilatency drug administration during HIV treatment.Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.
P2860
Q28544949-A8284B6B-92E8-4203-91AD-3478C24E31ECQ34132738-C391D493-5866-41BF-8C2D-5F049BD6AD98Q34482017-4D1B3145-3FEF-4529-8157-0CB5F92A51EFQ35016964-0DFD20C2-47C6-4BA1-8351-8B37618D5B2AQ35436367-DD2DA415-EC71-44B4-A74A-292B44CEC712Q36525896-6E6F9EE2-6859-4DBB-A4FF-5CB751912F16Q36901950-A1A17BE3-7DE3-44C2-8BA4-B4258F534652Q37062057-B65C18B1-3EDE-48AC-9869-BDDAC55C5524Q37119662-416C74D6-367A-40A6-92D4-249A260B49F5Q37413059-42680FD8-E691-4557-881E-2AF10B903CB8Q37626634-2EDCD6AB-9018-4774-AC1C-2665583199E5Q37849655-B87E82FB-4E46-4C88-86CC-3091CC4CB51EQ37956178-B3213E6B-6373-4CFF-8ABA-5CCEC6A84F40Q37976293-4C7B3620-68C7-49DF-8870-5B0181307117Q38206643-14C8306E-DF45-489B-908B-84A1FFCD168CQ39616690-1181348E-E49A-468F-88A2-BD692BB2D777Q39910687-A9F7E67F-91F8-404C-AD1B-E00857F0F9F1Q40331404-41C59A07-38A9-40FE-874B-B7F0B609C249Q41727164-D2C8AD80-3BD6-4376-ADA8-2A28F3BDCAFEQ41885967-02863979-CFF4-4FF3-81C4-FB04513BD3E1
P2860
The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The novel histone deacetylase ...... on in latently infected cells.
@en
The novel histone deacetylase ...... on in latently infected cells.
@nl
type
label
The novel histone deacetylase ...... on in latently infected cells.
@en
The novel histone deacetylase ...... on in latently infected cells.
@nl
prefLabel
The novel histone deacetylase ...... on in latently infected cells.
@en
The novel histone deacetylase ...... on in latently infected cells.
@nl
P2093
P50
P1433
P1476
The novel histone deacetylase ...... ion in latently infected cells
@en
P2093
Ajantha Solomon
David Rhodes
Hong B Liu
Miranda Shehu-Xhilaga
Suha Saleh
P304
P356
10.1097/QAD.0B013E328330342C
P407
P577
2009-09-01T00:00:00Z